$84.53
0.420.5%
Últ. Act.: Sep 25, 1:17 PM
10x Genomics Inc
TXGNASDAQ
10x Genomics Earnings & Forecasts
10x Genomics (TXG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
10x Genomics Guidance
10x Genomics (TXG) publicó su última previsión de agosto 6, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $610M - $630M para el período.
En comparación con la previsión anterior, 10x Genomics elevado redujo su previsión de ingresos desde un rango anterior de $600M - $625M.
10x Genomics ha emitido 22 actualizaciones de orientación entre el noviembre 2, 2022 y el agosto 6, 2026. During this period, the company raised its outlook 13 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.06 | $-0.10 | $-0.10 | $-0.15 |
| Actual | $-0.14 | $-0.10 | $-0.13 | $-0.22 |
| Surprise | -133.3% | 0.00% | -30.0% | -46.7% |
| Revenue | ||||
| Estimate | $146.7M | $146.4M | $159.1M | $142.5M |
| Actual | $151.0M | $150.8M | $166.0M | $149.0M |
| Surprise | +2.95% | +3.05% | +4.34% | +4.59% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.05 | $-0.08 | $-0.15 |
| Revenue | ||||
| Consensus | $147.6M | $171.1M | — | — |